Waning effectiveness against COVID-19-related hospitalization, severe complications, and mortality with two to three doses of CoronaVac and BNT162b2: a case–control study

Background: This study aims to evaluate waning effectiveness against severe and fatal COVID-19 with two to three doses of CoronaVac/BNT162b2, where data are limited. Methods: A case–control study included individuals aged ≥18 years, unvaccinated or received two to three doses of CoronaVac/BNT162b2,...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Vincent Ka Chun Yan, Eric Yuk Fai Wan, Xuxiao Ye, Anna Hoi Ying Mok, Francisco Tsz Tsun Lai, Celine Sze Ling Chui, Xue Li, Carlos King Ho Wong, Philip Hei Li, Tiantian Ma, Simon Qin, Chak Sing Lau, Ian Chi Kei Wong, Esther Wai Yin Chan
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Taylor & Francis Group 2023-12-01
Edice:	Emerging Microbes and Infections
Témata:	COVID-19 waning vaccine effectiveness CoronaVac BNT162b2 Omicron
On-line přístup:	https://www.tandfonline.com/doi/10.1080/22221751.2023.2209201
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!